ArticleScientific reports2022

Prebiopsy bpMRI and hematological parameter-based risk scoring model for predicting outcomes in biopsy-naive men with PSA 4-20 ng/mL.

Yuxin Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.